JAK1 and melanoma: Intriguingly, in B16F10 melanoma cells, PAI-1 promotes the release of soluble PD-L1 through JAK1/TYK2–STAT3 signaling, thereby suppressing CD8+ cytotoxic T-cell activity in a JAK-dependent manner [9].